RESUMO
Alcohol is often considered as a simple co-factor, potentiating the carcinogenic effect of tobacco, in head and neck cancer. However, its own effect is less clear. It has been recognized by the International Agency for Research on Cancer (IARC) as a risk factor for head and neck cancer for many years. It seems that the risk is a function of the importance of consumption, with certain genetic predispositions. This risk can also decrease if consumption stops, with a prolonged interruption. In addition, alcohol consumption may have a negative influence on the prognosis of patients with this type of cancer. A preventive action is therefore essential, among other things via information to the patient provided by health providers.
En cancérologie ORL, l'alcool est souvent considéré comme un simple co-facteur, potentialisant l'effet carcinogène du tabac. Son effet propre est moins clair. Il est pourtant reconnu par le Centre International de Recherche sur le Cancer (CIRC) comme un facteur de risque de cancer ORL depuis de nombreuses années. Il semble que le risque soit fonction de l'importance de la consommation, avec la contribution de certaines prédispositions génétiques. Ce risque peut également diminuer en cas d'arrêt de la consommation, moyennant un arrêt prolongé. Par ailleurs, la consommation d'alcool pourrait avoir une influence néfaste sur le pronostic des patients atteints de ces cancers. Une action préventive est donc primordiale, entre autres interventions, via l'information du patient par le corps médical.
Assuntos
Consumo de Bebidas Alcoólicas , Carcinoma de Células Escamosas , Neoplasias de Cabeça e Pescoço , Consumo de Bebidas Alcoólicas/efeitos adversos , Carcinoma de Células Escamosas/induzido quimicamente , Estudos de Casos e Controles , Neoplasias de Cabeça e Pescoço/induzido quimicamente , Humanos , Fatores de Risco , FumarRESUMO
Acute pharyngitis is one of the most common illnesses for which adults seek medical help from primary care physicians. Approximately 15% of cases in adults are caused by group A beta-hemolytic Streptococcus. Strategies of management should aim at identifying the latter with a view to prevent the development of complications. Rapid Antigen tests have a reported specificity of more than 95%. Antibiotic therapy is only recommanded for patients with positive rapid antigen test results and those with risk factors.
